Cafepharma.com

The NY Times with a profile. Unsurprisingly, they lack corporate support:

Not surprisingly, Cafepharma lacks corporate fans.

Pfizer, the subject of the site’s most popular bulletin board, declined repeated requests to discuss Cafepharma. Shreya Prudlo, a spokeswoman, said that Pfizer monitored every “communication channel” that reached its constituency, and that each needed to be “viewed based on their accuracy and integrity.”

Medtronic, which has the busiest Cafepharma bulletin board among device makers, said, “We do not endorse sites like this one.” It said it monitored Cafepharma periodically to see if confidential or proprietary information had been posted. Cindy Resman, a spokeswoman, said that Medtronic had not asked Cafepharma to remove any information yet.

(via bookofjoe)

✓ Join 150,000+ subscribers
✓ Get KevinMD's most popular stories